Official Korea FDA (MFDS) clinical trial phase 2B ongoing in Korea across 15 hospitals so far has shown 50-70% of test subjects showing consistent or improved cognitive function across four various standardized cognitive tests with zero reports of adverse
by 4alzheimers
·
3 years ago
·
via Instagram
Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr
by 4alzheimers
·
4 years ago
·
via Instagram
Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood
by 4alzheimers
·
4 years ago
·
via Instagram